Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000087-42Phase 4Terminated
Phase 4, open-label, single-arm trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by University College Dublin. Primary endpoint: Tolerability. Started Feb 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000087-42.